Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @CircAHA
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @CircAHA
-
Prikvačeni tweet
Call for Papers! Circulation again invites submissions representing the best of cardiovascular surgery science for the 2020 Cardiovascular Surgery-Themed Issue. Submit by March 1, 2020. Learn More: http://ow.ly/22dD50xErzj Read the previous issue here: http://ow.ly/Ct5A50xErzh pic.twitter.com/nnIKyPLaV8
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Circulation proslijedio/la je Tweet
Stent Only vs Adjunctive Balloon for
#SVG#PCI No difference in target vessel failure but
ST and MI with direct stenting(No
) by @FaisalLatifMD et al https://www.ahajournals.org/doi/full/10.1161/CIRCINTERVENTIONS.119.008494 …@CircAHA@CircOutcomes@JAHA_AHA#AHAJournals#ACCFIT#cardiotwitter#HeartMonth
pic.twitter.com/nucFPmYReq
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Editorial: Substance and Substrate: LVEF and Sex Subgroup Analyses of PARAGON-HF and PARADIGM-HF Trials http://ow.ly/KsO150ydfEs#AHAJournals@BiykemB@JustinEzekowitzpic.twitter.com/DASwS5GcEL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#EditorsPick: In combined PARADIGM/PARAGON-HF analysis, benefit of sacubitril/valsartan varies by LVEF, extends to#HFmrEF. Read more: http://ow.ly/I6Em50ydfmn@scottdsolomon@mvaduganathan@BrighamResearch#AHAJournalspic.twitter.com/mcgLqkUJgj
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#EditorsPick: In PARAGON-HF, sacubitril/valsartan reduced risk of HF hospitalization in women more than in men. Read more: http://ow.ly/at4o50ydf1D#AHAJournals@UofGlasgow@HFpEF@lamcardio@DrNancySweitzer@scottdsolomonpic.twitter.com/6FxJYZyOhv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Circulation proslijedio/la je Tweet
How do you
#stent pts with de novo#SVG lesions? PlsVT/RT@SVRaoMD@chadialraies@mmamas1973@manesh_patelMD@rajivxgulati@nadia_sutton@DrArgyle@EricSecemskyMD@Costa_F_8@DocSavageTJU@DLBHATTMD@FaisalLatifMD@CircAHA@CircOutcomes@AHAScience#cardiotwitter#ACCFITHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Perspective: Abolish the Tilt Table Test! http://ow.ly/Qq5G50ydeUe#AHAJournalsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#CircOnTheRun episode featuring corresponding author,@scottdsolomon & Senior Associate Editor,@BiykemB discussing Sacubitril/Valsartan Across Ejection Fraction Spectrum http://ow.ly/atgD50ycpL3 Featured Article: http://ow.ly/LaVQ50ycpL4#AHAJournalspic.twitter.com/OzDFDrNRkF
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#NewOnline AHA Presidential Advisory: Advancing Healthcare Reform: The AHA’s 2020 Statement of Principles for Adequate, Accessible & Affordable Health Care http://ow.ly/arHh50y7nTU@AHAScience#AHAJournalsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#CircOnTheRun episode featuring corresponding author,@Eric_Van_Belle and associate editors, Dr. Dharam Kumbhani &@dramitkhera discussing THV Design, PVR, & Mortality http://ow.ly/9w4k50y7icj Featured Article: http://ow.ly/O4A950y7ick#AHAJournalspic.twitter.com/0GfjL9g6yq
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Call for Papers! Submit your best cardiovascular surgery science for Circulation's 2020 Cardiovascular Surgery-Themed Issue. Submission deadline: March 1, 2020. Learn More: http://ow.ly/Xgiw50xPpNW Read the previous issue here: http://ow.ly/69UI50xPpNY
#AHAJournalspic.twitter.com/IHaD8blqyI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Circulation proslijedio/la je Tweet
TWEET CHAT! This Sunday (2/2) from 11AM–12PM EST...Join the
@CircIntv Twitter Journal Club and David Fischman, MD@fischman_david for a discussion on Ischemia and No Obstructive Coronary Artery Disease#INOCA. Use#CircIntvJC to participate. More info: http://spr.ly/60141gGiw pic.twitter.com/GRWu6Gxlem
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A rare subset of
#AF due to mutations in MYL4 appears to be dependent on pathways previously implicated in cardiac development http://ow.ly/C2E150y6eQ6#AHAJournals@KiviniemiTuoski@calum_ogpic.twitter.com/cUOoDmLgkC
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Transient treatment of human iPSC-derived cardiomyocytes with Torin1, a mTOR inhibitor, shifts cells to a quiescent state and enhances cardiomyocyte maturity http://ow.ly/cOuY50y6eIA
#AHAJournals@HSCRBpic.twitter.com/UPQSN9tqmN
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
#NewOnline Heart Disease & Stroke Statistics—2020 Update http://ow.ly/1Li450y7ohw#AHAJournals@AHAScienceHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#NewOnline: Recommendations for Cardiovascular Health and Disease Surveillance for 2030 and Beyond: A Policy Statement From the American Heart Association http://ow.ly/Ohq850xMK7d#AHAJournals@AHAScienceHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#NewOnline AHA Policy Statement: Recommendations for CV Health and Disease Surveillance for 2030 and Beyond http://ow.ly/aEox50y7nZ9#AHAJournals@AHAScienceHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#NewOnline AHA Presidential Advisory: The AHA 2030 Impact Goal http://ow.ly/Ri4l50y7o55#AHAJournals@AHAScienceHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Editorial: Transcatheter heart valve design and mortality: truth or dare?#AHAJournals http://ow.ly/8vpF50y6dr5Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Balloon-expandable
#TAVR was associated with lower mortality,#HF rehospitalization and pacemaker implantation compared with self-expanding#TAVR http://ow.ly/8VjZ50y6dii#AHAJournalspic.twitter.com/fd2ROrm1wG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.